Scope
Description
The identification and validation of cancer biomarkers requires highly sensitive and robust analytical technologies capable of delivering deep proteome coverage, reproducible quantitation, and confident peptide and protein identification. To support ongoing research in the next generation diagnostic programme at CPI Biologics, Darlington, supporting application to clinical proteomics, there is a need to procure a LC-MS system specifically optimised for advanced proteomics applications.
The LC-MS instrument will underpin discovery-to-validation workflows in cancer biomarker research, enabling both untargeted and targeted proteomics approaches within a single platform. It must demonstrate proven performance in single-cell proteomics, clinical proteomics, host cell protein analysis, and post-translational modification studies, with published evidence supporting its application in these domains. High resolution, sensitivity, dynamic range, and throughput are critical to ensure reliable detection of low-abundance proteins and post-translational modifications that are central to biomarker discovery.
The acquisition of this LC-MS system will provide the necessary technological foundation to accelerate biomarker discovery, improve clinical translation, and strengthen CPIs capabilities in proteomics.
Commercial tool
Establishes a framework
Total value (estimated)
- £0 including VAT
Above the relevant threshold
Contract dates (estimated)
- 10 March 2026 to 10 March 2030
- 4 years, 1 day
Main procurement category
Goods
CPV classifications
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
Framework
Maximum number of suppliers
Unlimited
Maximum percentage fee charged to suppliers
0%
Framework operation description
CPI will establish a Single supplier framework agreement, against which we will reserve the right to direct award
without further competition.
Award method when using the framework
Without competition
Contracting authorities that may use the framework
Establishing party only
Submission
Tender submission deadline
3 February 2026, 11:59pm
Submission address and any special instructions
Your response must be electronically uploaded to the website as stated in the link below only, to arrive in good
time, no later than the Bid Return Date:
12 noon Tuesday, 03 February 2026
Electronic Address for Document Access and Receipt of Bids:
Tenders may be submitted electronically
Yes
Languages that may be used for submission
English
Award decision date (estimated)
10 March 2026
Award criteria
| Name | Description | Type |
|---|---|---|
| Simple description | Will be ascertained by the combined scores out of 100% (see Award Criteria Ratio) as to whom is successfully awarded. Quality & Service Response 70% Price 30% TOTAL 100% |
Price |
Weighting description
Will be ascertained by the combined scores out of 100% (see Award Criteria Ratio) as to whom is successfully awarded.
Quality & Service Response 70%
Price 30%
TOTAL 100%
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Open procedure
Contracting authority
CENTRE FOR PROCESS INNOVATION LIMITED
- Companies House: 05002194
Wilton Centre
Redcar
TS10 4RF
United Kingdom
Email: e-tendering@uk-cpi.com
Website: http://uk-cpi.com
Region: UKC12 - South Teesside
Organisation type: Public undertaking (commercial organisation subject to public authority oversight)